| Product Code: ETC7538421 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India blockbuster oncology brands market import shipment depicted a steady growth trend with a CAGR of 3.0% from 2020 to 2024. Notably, the growth rate surged by 26.5% between 2023 and 2024, indicating a significant acceleration in market expansion during that period. This signifies a growing and dynamic market for oncology brands in India.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Blockbuster Oncology Brands Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 India Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 India Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 India Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 India Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising awareness about cancer treatment options and therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes |
4.3.2 High costs associated with oncology drugs |
4.3.3 Limited access to advanced cancer treatments in certain regions |
5 India Blockbuster Oncology Brands Market Trends |
6 India Blockbuster Oncology Brands Market, By Types |
6.1 India Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 India Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 India Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 India Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 India Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 India Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 India Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 India Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 India Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 India Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 India Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 India Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 India Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 India Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 India Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 India Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 India Blockbuster Oncology Brands Market Export to Major Countries |
7.2 India Blockbuster Oncology Brands Market Imports from Major Countries |
8 India Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Patient survival rates |
8.2 Adoption rates of innovative oncology treatments |
8.3 Number of oncology clinical trials conducted in India |
8.4 Rate of adoption of personalized medicine in cancer treatment |
8.5 Patient satisfaction scores with oncology services |
9 India Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 India Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 India Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 India Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 India Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here